Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Ferrol (16)

2024

  1. Efficacy of Beclomethasone Dipropionate in Lowering Fecal Calprotectin Levels in Patients with Ulcerative Colitis in Clinical Remission and at Risk of Relapse: The Becalcu Randomized, Controlled Trial

    Digestive Diseases

2023

  1. Optimizing treatment of mild to moderate ulcerative colitis: CU-forum Delphi consensus

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 10, pp. 784-794

2022

  1. Caso clínico MIR. Haz tu diagnóstico Una causa no infrecuente de disfagia en Pediatría

    Pediatria Integral, Vol. 26, Núm. 7, pp. 442.e1-442.e7

  2. Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab

    Journal of Clinical Medicine, Vol. 11, Núm. 15

2021

  1. Impact of biological agents on postsurgical complications in inflammatory bowel disease: A multicentre study of geteccu

    Journal of Clinical Medicine, Vol. 10, Núm. 19

2019

  1. Quality of life during one year of postoperative prophylactic drug therapy after intestinal resection in Crohn's patients: Results of the APPRECIA trial

    Digestive and Liver Disease, Vol. 51, Núm. 4, pp. 529-535

2017

  1. Adalimumab vs azathioprine in the prevention of postoperative Crohn's disease recurrence. A GETECCU randomised trial

    Journal of Crohn's and Colitis, Vol. 11, Núm. 11, pp. 1293-1301

2015

  1. Exome-wide pharmacogenomic analysis of response to thiopurines in inflammatory bowel disease patients

    Current Pharmacogenomics and Personalized Medicine, Vol. 13, Núm. 1, pp. 61-67

  2. Influence of urban/rural and coastal/inland environment on the prevalence, phenotype, and clinical course of inflammatory bowel disease patients from northwest of Spain: A cross-sectional study

    European Journal of Gastroenterology and Hepatology, Vol. 27, Núm. 9, pp. 1030-1037

2014

  1. Management of complications related to intraduodenal infusion of levodopa/carbidopa in patients with Parkinson's disease

    Revista de Neurologia, Vol. 58, Núm. 11, pp. 505-515

2013

  1. New genetic associations in thiopurine-related bone marrow toxicity among inflammatory bowel disease patients

    Pharmacogenomics, Vol. 14, Núm. 6, pp. 631-640

2010

  1. Artificial intelligence techniques for colorectal cancer drug metabolism: Ontologies and complex networks

    Current Drug Metabolism, Vol. 11, Núm. 4, pp. 347-368

  2. Clinical practice in Crohn's disease in bordering regions of two countries: Different medical options, distinct surgical events

    Journal of Crohn's and Colitis, Vol. 4, Núm. 3, pp. 301-311

  3. Experiencia con la infusión continua de levodopa intraduodenal (Duodopa®) en pacientes con enfermedad de Parkinson avanzada en un hospital de segundo nivel asistencial

    Neurologia, Vol. 25, Núm. 9, pp. 536-543

  4. Ulcerative colitis in northern Portugal and Galicia in Spain

    Inflammatory Bowel Diseases, Vol. 16, Núm. 7, pp. 1227-1238

2008

  1. Obesidad y esteatohepotitis no alcohólica - Su interrelación y estudio

    Revista Espanola de Obesidad, Vol. 6, Núm. 6, pp. 317-328